By identifying IFN expression patterns in RA and JIA, as well as among different JIA subtypes, this study seeks to provide insights into disease pathology and guide the development of targeted anti-IFN therapies. This evidence concerns the gene IFNA1 and juvenile idiopathic arthritis.